Opportunity ID: 329515

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-037
Funding Opportunity Title: Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 20, 2020
Last Updated Date: Oct 20, 2020
Original Closing Date for Applications: Jul 28, 2023
Current Closing Date for Applications: Jul 28, 2023
Archive Date: Sep 02, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); See funding announcement for eligibility details

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-037.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 329515 Full Announcement-PAR-21-037 -> PAR-21-037-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00263840 Jun 28, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00269581 Oct 27, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277590 Oct 31, 2022 Jul 28, 2023 View

Package 1

Mandatory forms

329515 RR_SF424_2_0-2.0.pdf

329515 PHS398_CoverPageSupplement_5_0-5.0.pdf

329515 RR_OtherProjectInfo_1_4-1.4.pdf

329515 PerformanceSite_2_0-2.0.pdf

329515 RR_KeyPersonExpanded_2_0-2.0.pdf

329515 RR_Budget_1_4-1.4.pdf

329515 PHS398_ResearchPlan_4_0-4.0.pdf

329515 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

329515 RR_SubawardBudget30_1_4-1.4.pdf

329515 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

329515 RR_SF424_5_0-5.0.pdf

329515 PHS398_CoverPageSupplement_5_0-5.0.pdf

329515 RR_OtherProjectInfo_1_4-1.4.pdf

329515 PerformanceSite_4_0-4.0.pdf

329515 RR_KeyPersonExpanded_4_0-4.0.pdf

329515 RR_Budget_3_0-3.0.pdf

329515 PHS398_ResearchPlan_4_0-4.0.pdf

329515 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

329515 RR_SubawardBudget30_3_0-3.0.pdf

329515 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

329515 RR_SF424_5_0-5.0.pdf

329515 PHS398_CoverPageSupplement_5_0-5.0.pdf

329515 RR_OtherProjectInfo_1_4-1.4.pdf

329515 PerformanceSite_4_0-4.0.pdf

329515 RR_KeyPersonExpanded_4_0-4.0.pdf

329515 RR_Budget_3_0-3.0.pdf

329515 PHS398_ResearchPlan_5_0-5.0.pdf

329515 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

329515 RR_SubawardBudget30_3_0-3.0.pdf

329515 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T16:54:10-05:00

Share This Post, Choose Your Platform!

About the Author: